Several studies demonstrated an association of the hetreodimeric CD227 (MUC1) with breast cancer development, whereby MUC1 is involved in the regulation of the p53 gene and is aberrantly glycosylated in mammary tumors [22-24]. This evidence concerns the gene MUC1 and breast carcinoma.